Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Tilchen
E J
EJ
Henry Ford Hospital, Detroit, MI.
Fleming
T
T
Mills
G
G
Oishi
N
N
Bonnett
J D
JD
Natale
R B
RB
Harker
G
G
Coltman
C A
CA
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D001388:Aziridines / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D016227:Benzoquinones; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*
D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; C029108:diaziquone